Table 1 Age and gender balance of the individuals in all subgroups. Age difference between the NDB and test group was not significant (Mann–Whitney U test, p = 0.93)
From: Same same but different: dopamine transporter SPECT on scanners with CZT vs. NaI detectors
Count | Median age (IQR) | Proportion female | |
|---|---|---|---|
Total sample | 73 | 67 (61 to 75) | 0.37 (27/73) |
Non-neurodegenerative PS | 39 | 71 (60 to 75) | 0.41 (16/39) |
Neurodegenerative PS | 34 | 67 (62 to 75) | 0.32 (11/34) |
Crossover group | 32 | 67 (57 to 77) | 0.38 (12/32) |
Non-neurodegenerative PS | 16 | 68 (59 to 78) | 0.50 (8/16) |
Neurodegenerative PS | 16 | 66 (54 to 77) | 0.25 (4/16) |
CZT NDB group | 25 | 67 (64 to 75) | 0.52 (13/25) |
Test group | 48 | 67 (60 to 76) | 0.29 (14/48) |
Non-neurodegenerative PS | 14 | 73 (56 to 77) | 0.21 (3/14) |
Neurodegenerative PS | 34 | 67 (62 to 75) | 0.32 (11/34) |